Document:

Form of Subscription  Agreement

 Exhibit 10.1 
 FORM OF SUBSCRIPTION AGREEMENT 
 Buckeye Partners, L.P. 

One Greenway Plaza 
 Suite 600 

Houston, Texas 77046 
 Gentlemen: 

The undersigned (the “Investor”) hereby confirms its agreement with Buckeye Partners, L.P., a Delaware limited
partnership (the “Partnership”), as follows: 
 1. This Subscription Agreement, including the Terms and
Conditions for Purchase of LP Units attached hereto as Annex I (collectively, this “Agreement”), is made as of the date set forth below between the Partnership and the Investor. 

2. The Partnership represents and warrants that it has authorized the sale and issuance to certain investors of up to an aggregate
of             (    ,    ,    ) units representing limited partnership interests in the Partnership (the “LP
Units”), for a purchase price of $            per LP Unit (the “Purchase Price”). 
 3. The Partnership represents and warrants that the offering and sale of the LP Units (the “Offering”) are being made pursuant to (a) an effective Registration Statement on
Form S-3 (Registration No. 333-178160) (the “Registration Statement”) filed by the Partnership with the Securities and Exchange Commission (the “Commission”), including the Prospectus contained therein (the
“Base Prospectus”), (b) if applicable, certain “free writing prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended (the “Act”)), that have been or will be
filed with the Commission and delivered to the Investor on or prior to the date hereof (the “Issuer Free Writing Prospectus”), containing certain supplemental information regarding the LP Units and the terms of the Offering, and
(c) a Prospectus Supplement (the “Prospectus Supplement” and, together with the Base Prospectus, the “Prospectus”) containing certain supplemental information regarding the Partnership, the LP Units and terms
of the Offering that have been or will be (i) filed with the Commission, and (ii) delivered to the Investor (or made available to the Investor by the filing by the Partnership of an electronic version thereof with the Commission).

 4. The Partnership and the Investor agree that the Investor will purchase from the Partnership and the Partnership will
issue and sell to the Investor the LP Units set forth below for the aggregate purchase price set forth below. The LP Units shall be purchased pursuant to the Terms and Conditions for Purchase of LP Units attached hereto as Annex I and
incorporated herein by this reference as if fully set forth herein. The Investor acknowledges that the Offering is not being underwritten by the placement agents (the “Placement Agents”) named in the Prospectus Supplement and that
there is no minimum offering amount. 
 5. The Investor represents that, except as set forth below, (a) it has had no
material relationship (exclusive of any investments by the Investor in the Partnership’s securities) within the past three years with the Partnership or persons known to it to be affiliates of the Partnership and (b) it is not a FINRA
member or an Associated Person of a FINRA member (as such term is defined under the NASD Membership and Registration Rules Section 1011) as of the Closing. Exceptions: 

 The representations above are made to the knowledge of the signatory
below. (If no exceptions, write “none.” If left blank, response will be deemed to be “none.”) 
 6.
The Investor represents that it has received (or otherwise had made available to it by the filing by the Partnership of an electronic version thereof with the Commission) the Base Prospectus which is a part of the Partnership’s Registration
Statement, the documents incorporated by reference therein and any Issuer Free Writing Prospectus (collectively, the “Filed Documents”), prior to or in connection with the receipt of this Agreement. The Investor acknowledges that,
prior to the delivery of this Agreement by the Investor to the Partnership, the Investor will receive certain additional information regarding the Partnership and the Offering, including pricing information (the “Offering
Information” and, collectively with the Filed Documents, the “Disclosure Package”). Such information may be provided to the Investor by any means permitted under the Act, including the Prospectus Supplement, a free writing
prospectus and oral communications, including any live, confidential management presentation.  
 7. No offer by
the Investor to buy LP Units will be accepted and no part of the Purchase Price will be delivered to the Partnership until the Investor has received the Offering Information and the Partnership has accepted such offer by countersigning a copy of
this Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to the Partnership (or any of the Placement Agents on behalf of the Partnership) sending (orally, in writing or by
electronic mail) notice of its acceptance of such offer. An indication of interest will involve no obligation or commitment of any kind until the Investor has been delivered the Offering Information and this Agreement is accepted and countersigned
by or on behalf of the Partnership. 
 [Remainder of Page Left Blank Intentionally. Signature Page Follows.] 

  
 2 

  

			
	Number of LP Units:	  	
		
	Purchase Price Per LP Unit: $	  	
		
	Aggregate Purchase Price: $	  	

 Please confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below
for that purpose. 
  

			
		  	Dated as of:                     , 2012
		
		  	  

		  	INVESTOR
		
		  	By:
                                         
                                         
                                 
		  	Print Name:
                                         
                                         
                
		  	Title:
                                         
                                         
                             
		  	Address:
                                         
                                         
                       
		  	  

		
		  	E-mail:
		  	Phone:
                                         
                                         
                          

  

			
	 Agreed and Accepted

this          day of
                 , 2012:

	
	BUCKEYE PARTNERS, L.P.
		
	By:	 	 Buckeye GP LLC,
 its General
Partner

		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 3 

 ANNEX I 

TERMS AND CONDITIONS FOR PURCHASE OF LP UNITS 
 1. Authorization and Sale of the Securities. Subject to the terms and conditions of this Agreement, the Partnership has authorized the sale of the LP Units. 

2. Agreement to Sell and Purchase the LP Units; Placement Agents. 

2.1 At the Closing (as defined in Section 3.1), the Partnership will sell to the Investor, and the Investor will
purchase from the Partnership, upon the terms and conditions set forth herein, the number of LP Units set forth on the last page of the Agreement to which these Terms and Conditions for Purchase of LP Units are attached as Annex I (the
“Signature Page”) for the aggregate purchase price therefor set forth on the Signature Page. 
 2.2 The
Partnership proposes to enter into substantially this same form of Subscription Agreement with certain other investors (the “Other Investors”) and expects to complete sales of LP Units to them. The Investor and the Other Investors,
if any, are hereinafter collectively referred to as the “Investors,” and this Agreement and the Subscription Agreements executed by the Other Investors are hereinafter collectively referred to as the “Agreements.”

 2.3 Investor acknowledges that the Partnership has agreed to pay the Placement Agents a fee (the “Placement
Fee”) in respect of the sale of LP Units to the Investor. 
 2.4 Except for the Offering Information, the
Partnership confirms that neither it nor any other person acting on its behalf has provided the Investor or any Other Investor or its respective agents or counsel with any information that constitutes or could reasonably be expected to constitute
material, non-public information. The Partnership understands and confirms that the Investor will rely on the foregoing representations in effecting transactions in securities of the Partnership. 

3. Closings and Delivery of the LP Units and Funds. 

3.1 Closing. The completion of the purchase and sale of the LP Units (the “Closing”) shall
occur, in accordance with Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, and unless otherwise agreed upon by the Partnership and Barclays Capital Inc. (the “Lead Placement Agent”), at Vinson & Elkins
L.L.P., 666 Fifth Avenue, 25th Floor, New York, New York
at 10:00 am Eastern time on Tuesday, February 14, 2012 (the “Closing Date”). At the Closing, (a) the Partnership shall cause to be delivered to the Investor the number of LP Units set forth on the Signature Page registered
in the name of the Investor or, if so indicated on the Investor Questionnaire attached hereto as Exhibit A, in the name of a nominee designated by the Investor and (b) the aggregate purchase price for the LP Units being purchased by the
Investor will be delivered by or on behalf of the Investor to the Partnership. 

  
 I-1

 3.2 Conditions to the Obligations of the Parties. 

(a) Conditions to the Partnership’s Obligations. The Partnership’s obligation to issue and sell the LP
Units to the Investor shall be subject to: (i) the delivery by the Investor, in accordance with the provisions of this Agreement, of the purchase price for the LP Units being purchased hereunder as set forth on the Signature Page and
(ii) the accuracy of the representations and warranties made by the Investor in this Agreement and the fulfillment of those undertakings of the Investor in this Agreement to be fulfilled prior to the Closing Date. 

(b) Conditions to the Investor’s Obligations. The Investor’s obligation to purchase the LP Units
will be subject to (i) the delivery by the Partnership of the LP Units in accordance with the provisions of this Agreement, (ii) the accuracy of the representations and warranties made by the Partnership and the fulfillment of those
undertakings of the Partnership to be fulfilled prior to the Closing Date, in each case as contained in this Agreement, and (iii) the condition that the Lead Placement Agent shall not have: (x) terminated the Placement Agency Agreement,
dated February 9, 2012 (the “Placement Agreement”) pursuant to the terms thereof or (y) determined that the conditions to the closing in the Placement Agreement have not been satisfied. The Investor’s obligations are
expressly not conditioned on the purchase by any or all of the Other Investors of the LP Units that they have agreed to purchase from the Partnership. The Investor understands and agrees that, in the event that the Lead Placement Agent determines
that the conditions to closing in the Placement Agreement have not been satisfied or if the Placement Agreement may be terminated for any other reason permitted by the Placement Agreement, then the Lead Placement Agent, may, but shall not be
obligated to, terminate such Agreement, which shall have the effect of terminating this Subscription Agreement pursuant to Section 13 below. 
 3.3 Delivery of Funds. In order to effect the settlement of the LP Units purchased by such Investor with the Depository Trust Company (“DTC”) through its Deposit/Withdrawal At
Custodian (“DWAC”) system, on the Closing Date, the Investor shall remit by wire transfer the amount of funds equal to the aggregate purchase price for the LP Units being purchased by the Investor to the following account designated
by the Partnership: 
 Bank Name: 
 ABA # 
 Account Name: 

Account Number: 

  
 I-2

 3.4 Delivery of LP Units. In order to effect the settlement of the LP Units purchased
by such Investor through the DTC’s DWAC delivery system, no later than 9:00 a.m. Eastern Time, February 14, 2012, the Investor shall direct the broker-dealer at which the account or accounts to be credited with the LP Units being
purchased by such Investor are maintained, which broker/dealer shall be a DTC participant, to set up a DWAC instructing American Stock Transfer & Trust Company, LLC, the Partnership’s transfer agent (the “Transfer
Agent”), to credit such account or accounts with the LP Units. Such DWAC instruction shall indicate the settlement date for the deposit of the LP Units, which date shall be the Closing Date. At the Closing, the Partnership shall direct the
Transfer Agent to credit the Investor’s account or accounts with the LP Units pursuant to the information contained in the DWAC. 
 4. Survival of Representations, Warranties and Agreements. Notwithstanding any investigation made by any party to this Agreement or by any of the Placement Agents, all covenants, agreements,
representations and warranties made by the Partnership and the Investor herein will survive the execution of this Agreement, the delivery to the Investor of the LP Units being purchased and the payment therefor. 

5. Notices. All notices, requests, consents and other communications hereunder will be in writing, will be mailed (a) if
within the domestic United States by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered from outside the United States, by International Federal
Express or facsimile, and (c) will be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier, one business
day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and (iv) if delivered by facsimile, upon electric confirmation of receipt and will be delivered and addressed as follows:

  

	 	(a)	if to the Partnership, to: 

 Buckeye Partners, L.P. 
 One Greenway Plaza 

Suite 600 
 Houston, Texas 77046 
 Attention: William H. Schmidt, Jr.

 Facsimile No.: 610-904-4006 

(b)   if to the Investor, at its address on the Signature Page hereto, or at such other address
or addresses as may have been furnished to the Partnership in writing. 
 6. Changes. This Agreement may not be modified
or amended except pursuant to an instrument in writing signed by the Partnership and the Investor. 
 7. Headings. The
headings of the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement. 
 8. Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions
contained herein will not in any way be affected or impaired thereby. 

  
 I-3

 9. Governing Law. This Agreement will be governed by, and construed in accordance
with, the internal laws of the State of New York, without giving effect to the principles of conflicts of law that would require the application of the laws of any other jurisdiction. Except as set forth below, no proceeding may be commenced,
prosecuted or continued in any court other than the courts of the State of New York located in the City and County of New York or the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the
adjudication of such matters, and the parties hereby consent to the jurisdiction of such courts and personal service with respect thereto. All parties hereby waive all right to trial by jury in any proceeding (whether based upon contract, tort or
otherwise) in any way arising out of or relating to this Agreement. All parties agree that a final judgment in any such proceeding brought in any such court shall be conclusive and binding upon each party and may be enforced in any other courts in
the jurisdiction of which a party is or may be subject, by suit upon such judgment. 
 10. Counterparts. This Agreement
may be executed in two or more counterparts, each of which will constitute an original, but all of which, when taken together, will constitute but one instrument, and will become effective when one or more counterparts have been signed by each party
hereto and delivered to the other parties. Delivery of an executed counterpart by facsimile or portable document format (.pdf) shall be effective as delivery of a manually executed counterpart thereof. 

11. Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt of the Partnership’s signed
counterpart to this Agreement, together with the Prospectus Supplement (or the filing by the Partnership of an electronic version thereof with the Commission), shall constitute written confirmation of the Partnership’s sale of LP Units to such
Investor. 
 12. Press Release. The Partnership and the Investor agree that, prior to the opening of the New York Stock
Exchange in New York City on the business day immediately after the date hereof, the Partnership shall (i) issue a press release announcing the Offering and disclosing all material information disclosed to the Investors regarding the Offering
and the Partnership and (ii) file a Current Report on Form 8-K with the Commission disclosing all required information, including the Placement Agreement as an exhibit thereto. From and after the issuance of such press release and the filing of
such Current Report on Form 8-K, the Partnership shall have publicly disclosed all material, non-public information delivered to any of the Investors by the Partnership or any person acting on its behalf, including, without limitation, any of the
Placement Agents, in connection with the transactions contemplated by this Agreement, the Placement Agreement and any other documents or agreements contemplated hereby or thereby. The Partnership shall not identify the name of any Investor or any
affiliate of any investment adviser of such Investor in any press release or public filing, or otherwise publicly disclose the name of any Investor or any affiliate of investment adviser of such Investor, without such Investor’s prior written
consent, unless required by law or the rules and regulations of a national securities exchange. 
 13. Termination. In
the event that the Placement Agreement is terminated by the Lead Placement Agent pursuant to the terms thereof, this Agreement shall terminate without any further action on the part of the parties hereto. 

  
 I-4

 14. Fees and Expenses. Each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. 

  
 I-5

 EXHIBIT A 

BUCKEYE PARTNERS, L.P. 
 INVESTOR QUESTIONNAIRE 
 Pursuant to Section 3 of Annex
I to the Agreement, please provide us with the following information: 
  

					
	 1.      The exact name that your LP Units are to be registered in. You may use a nominee name if
appropriate:
	 		    	 
	 2.      The relationship between the Investor and the registered holder listed in response to item
1 above:
	 		    	 
	 3.      The mailing address of the registered holder listed in response to item 1
above:
	 		    	 
	 4.      The Social Security Number or Tax Identification Number of the registered holder listed in
the response to item 1 above:
	 		    	 
	 5.      Name of DTC Participant (broker-dealer at which the account or accounts to be credited with
the LP Units are maintained):
	 		    	 
	 6.      DTC Participant Number:
	 		    	 
	 7.      Name of Account at DTC Participant being credited with the LP Units:
	 		    	 
	 8.      Account Number at DTC Participant being credited with the LP Units:
	 		    	 
	 9.      EIN Number:
	 		    	 

  
 A-1Non-Executive Chairman Agreement

 Exhibit 10.2 
 NON-EXECUTIVE CHAIRMAN AGREEMENT 
 This NON-EXECUTIVE CHAIRMAN
AGREEMENT (this “Agreement”), is entered into as of February 8, 2012, by and between by and between Buckeye GP LLC (“Buckeye GP”), a Delaware limited liability company and the general partner of Buckeye
Partners, L.P., a Delaware limited partnership (“BPL”), and Forrest E. Wylie (the “Chairman”). Each of Buckeye GP and the Chairman hereinafter may be referred to individually as a “Party” or,
collectively, as the “Parties.” 
 RECITALS 

WHEREAS, the Chairman was elected to be the Chief Executive Officer and Chairman of the Board of Directors (the
“Board”) of Buckeye GP on June 25, 2007; 
 WHEREAS, on January 13, 2012, the Chairman
informed the Board of his decision to resign as the Chief Executive Officer of Buckeye GP effective as of February 10, 2012, and in connection with such resignation, will resign as an officer and employee of all entities related to BPL,
including Buckeye Pipe Line Services Company (“BPLSC”); 
 WHEREAS, the Chairman has agreed to continue
to serve as the non-executive Chairman of the Board; and 
 WHEREAS, Buckeye GP wishes to receive certain additional
services from the Chairman related to his position as non-executive Chairman of the Board, and the Chairman wishes to provide such services on the terms and subject to the conditions of this Agreement. 

NOW, THEREFORE, in consideration of the mutual promises hereinafter set forth and intending to be legally bound hereby, the
Parties hereby agree as follows: 
 1. Term. This Agreement shall be effective as of February 10, 2012 (the
“Commencement Date”) and shall continue until the earlier of (i) thirty-six (36) months following the Commencement Date or (ii) the date upon which the Chairman is no longer the non-executive Chairman of the Board
(“Term”). From and after the Commencement Date, the Chairman shall serve as the Chairman of the Board in a non-executive capacity and shall not be either an employee or officer of Buckeye GP. The Chairman may serve on one or more
committees of the Board consistent with Section 2 below. 
 2. Services to be Provided. During the Term, the Chairman shall,
in a manner consistent with the listing standards of the New York Stock Exchange, BPL’s Corporate Governance Guidelines and other applicable legal standards: (a) regularly attend and preside at Board meetings, (b) chair the annual
meeting of BPL’s unitholders, (c) be eligible to serve on such committees of the Board as may be requested by the Board, subject to requisite independence standards, and (d) to the extent requested by and in coordination with Buckeye
GP’s Chief Executive Officer or the Board, provide support in connection with (i) strategic planning initiatives; (ii) industry marketing efforts; (iii) investor relations; and (iv) such other tasks as may be determined by
the Chief Executive Officer or the Board and the Chairman (collectively referred to herein as “Services”). 

 3. Commitment. During the Term, the Chairman will devote such reasonable time, attention,
skill and efforts to the Services as is necessary to discharge the duties and responsibilities assigned to the Chairman hereunder and shall serve Buckeye GP and BPL faithfully and to the best of his ability. 

4. Compensation; No Benefits. 
 (a) Compensation. During the Term, the Chairman shall be entitled to receive an annual stipend in the amount of One Hundred Eighty Thousand Dollars ($180,000), which amount shall be in lieu of and
not in addition to any cash directors’ fees and other compensation paid to other non-employee members of the Board. Payments to the Chairman set forth in this Section 4.1 shall be made quarterly by BPLSC in accordance with BPLSC’s
customary pay practices for BPL Directors. 
 (b) Equity Awards. So long as the Chairman continues unbroken service as a
member of the Board in accordance with this Agreement, all outstanding equity awards granted under BPL’s Long-Term Incentive Plan and Unit Deferral and Incentive Plan that are set forth on Exhibit A (the “Equity Awards”)
shall continue to vest and shall otherwise operate in accordance with their existing terms. For the avoidance of doubt, continued service as a member of the Board in accordance with this Agreement shall be treated as continued service with BPL for
purposes of vesting of such Equity Awards. 
 (c) Administrative Support. During the Term, BPL will provide the Chairman
with administrative support and office space as reasonably requested to fulfill his duties as the Chairman. 
 (d) No
Benefits. The Chairman will not be an employee of Buckeye GP, BPLSC, BPL or any or their affiliates (collectively, the “BPL Entities”), and, except as set forth in this Agreement, will not be entitled to participate in or
receive any benefit or right as an employee of any BPL Entity under any BPL Entity employee benefit or executive compensation plan, including, without limitation, employee insurance, pension, savings, medical, health care, fringe benefit, equity
compensation, deferred compensation or bonus plans, as a result of entering into this Agreement. If for any reason the Chairman’s status is re-characterized by a third party to constitute employee status, the Chairman shall not be eligible to
participate in or receive any benefit or right as a BPL Entity employee under any BPL Entity plan. 
 5. Independent Contractor.
For purposes of this Agreement and all the Services to be provided hereunder, the Chairman shall not be considered a partner, co-venturer, employee, agent or representative of BPL (other than solely in his capacity as a member of the Board), but
shall remain in all respects an independent contractor, and neither Party shall have any right or authority to make or undertake any promise, warranty or representation, to execute any contract, or otherwise to assume any obligation or
responsibility in the name of or on behalf of the other Party, solely as a result of the entry into this Agreement. 

  
 2 

 6. Restrictive Covenants. 

(a) Confidential Information. The Chairman recognizes and acknowledges that, by reason of his relationship to the BPL Entities, he
has had and will continue to have access to confidential information of the BPL Entities, including, without limitation, information and knowledge pertaining to products and services offered, innovations, designs, ideas, plans, trade secrets,
proprietary information, distribution and sales methods and systems, sales and profit figures, customer and client lists, and relationships among the BPL Entities and with the customers of the BPL Entities (“Confidential
Information”). The Chairman acknowledges that such Confidential Information is a valuable and unique asset and covenants that he will not, either during or after the Term, disclose or use any such Confidential Information to any person for
any reason whatsoever without the prior written authorization of Buckeye GP; unless such information is in the public domain through no fault of the Chairman or except as may be required by law. 

(b) Non-Competition and Non-Solicitation. 
 (i) For a three (3) year period following the Commencement Date (the “Restriction Period”), the Chairman will not, unless acting with the prior written consent of Buckeye GP,
directly or indirectly, own, manage, operate, join, control or participate in the ownership, management, operation or control, or be connected as an officer, director, manager, member, employee, partner, principal, agent, representative, consultant
or otherwise with or use or permit his name to be used in connection with (each of the foregoing actions being referred to herein as “Participate”), any business or enterprise, anywhere in the world (the “Geographic
Area”), that competes with any existing material line of business of the BPL Entities. It is recognized by the Chairman that the BPL Entities’ business and the Chairman’s connection therewith is or will be involved in activity
throughout the Geographic Area, and that more limited geographical limitations on this non-competition covenant are therefore not appropriate. The Chairman also shall not, unless acting with the prior written consent of Buckeye GP, directly or
indirectly, during the Restriction Period (1) solicit or divert business from, or attempt to convert any client, account or customer of the BPL Entities, whether existing at the date hereof or acquired during the Term nor (2) solicit or
attempt to hire any employee of the BPL Entities or any person who has been an employee of the BPL Entities at any time during the Term (unless such employee’s employment with a BPL Entity was terminated by such BPL Entity). 

(ii) During the Restriction Period, if the Chairman becomes aware of an opportunity involving the acquisition or development of
businesses or assets in any existing material line of business of the BPL Entities (an “Opportunity”), then the Chairman shall, prior to Participating in such Opportunity, present it to the Board in writing. Within five
(5) business days after the Board’s receipt of the Chairman’s written notice of such Opportunity, Buckeye GP shall respond to the Chairman in writing as to whether the BPL Entities desire to pursue such Opportunity. If Buckeye GP
timely notifies the Chairman that it desires to pursue such Opportunity, then the Chairman shall not pursue such Opportunity with any business or enterprise other than the BPL Entities for so long as the BPL Entities are actively pursuing such
Opportunity. 
 (iii) The foregoing restriction shall not be construed to prohibit the ownership by the Chairman of less than
five percent (5%) of any class of securities of any entity which is engaged in any of the foregoing businesses having a class of securities registered pursuant to the Securities Exchange Act of 1934, as amended, provided that such ownership
represents a passive investment and that neither the Chairman nor any group of persons including the Chairman in 

  
 3 

 
any way, either directly or indirectly, manages or exercises control of any such corporation, guarantees any of its financial obligations, otherwise takes any part in its business, other than
exercising his rights as a shareholder, or seeks to do any of the foregoing. 
 (c) Enforcement. If, in connection with
the enforcement of Sections 6(a) and (b), a court holds that the duration or scope restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration or scope reasonable under such
circumstances shall be substituted for the stated duration or scope and that the court shall be permitted to revise the restrictions contained in this Section 6 to cover the maximum duration and scope permitted by law. 

7. Equitable Relief. The Chairman acknowledges that (a) the covenants contained herein are reasonable, (b) the Chairman’s
services are unique, and (c) a breach or threatened breach by him of any of his covenants and agreements contained in Section 6 could cause irreparable harm to the BPL Entities for which Buckeye GP would have no adequate remedy at law.
Accordingly, and in addition to any remedies which Buckeye GP may have at law, in the event of an actual or threatened breach by the Chairman of his covenants and agreements contained in Section 6, Buckeye GP shall have the absolute right to
apply to any court of competent jurisdiction for such injunctive or other equitable relief as such court may deem necessary or appropriate in the circumstances. 
 8. Section 409A. This Agreement shall be interpreted to avoid any penalty sanctions under section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). If
any payment for the Services cannot be provided or made at the time specified herein without incurring sanctions under section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not
be imposed. Any reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of section 409A. 
 9. No Conflicting Agreements. The Chairman represents that the Chairman is not a party to any existing agreement that would prevent the Chairman from entering into and performing this
Agreement. The Chairman shall not, unless acting with the prior written consent of Buckeye GP, enter into any other agreement that is in conflict with the Chairman’s obligations under this Agreement. 

10. Taxes. Any and all taxes applicable to any payments made by the BPL Entities to the Chairman under this Agreement above shall be the
sole responsibility and liability of the Chairman. The Chairman shall bear all expense of, and be solely responsible for, all federal, state, and local taxes due with respect to any payment received under this Agreement. The Chairman understands and
acknowledges that the BPL Entities will file whatever instruments are required by law in connection with this Agreement, including, without limitation, Form 1099 under the Code (or any successor form thereto). 

  
 4 

 11. Miscellaneous Provisions. 

(a) Entire Agreement, Amendment, and Assignment. Except as otherwise provided in a separate writing between the Parties, this
Agreement is the sole agreement between the Chairman and the BPL Entities with respect to the Services to be performed hereunder, and it supersedes all prior agreements and understandings with respect thereto, whether oral or written. No
modification to any provision of this Agreement shall be binding unless in writing and signed by the Parties hereto. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the
respective heirs, executors, administrators, legal representatives, successors and permitted assigns of the Parties hereto. 

(b) Descriptive Headings. Descriptive headings are for convenience only and shall not control or affect the meaning or
construction of any provisions of this Agreement. 
 (c) Notices. All notices and other communications required or
permitted hereunder or necessary or convenient in connection herewith shall be in writing and shall be delivered personally or mailed by registered or certified mail, return receipt requested, or by overnight express courier service, as follows:

 (i) If to Buckeye GP, to: 
 Buckeye GP LLC 
 One Greenway Plaza 

Suite 600 

Houston, Texas 

Attention: General Counsel 
 (ii) If to the Chairman, to the most recent address on file with BPL. 
 Either
Party may provide other names or addresses, as the case may be, as designated by notice to each other person entitled to receive notices in the manner specified in this Section; provided, however, that if no such notice is given by Buckeye GP,
notice at the last address of Buckeye GP shall be deemed sufficient for the purposes hereof. Any such notice shall be deemed delivered and effective when received in the case of personal delivery, five (5) days after deposit, postage prepaid,
with the U.S. Postal Service in the case of registered or certified mail, or on the next business day in the case of overnight express courier service. 
 (d) Counterparts. This Agreement may be executed in any number of counterparts, and each such counterpart shall be deemed to be an original instrument, but all such counterparts together shall
constitute but one agreement. This Agreement may be executed and delivered by facsimile or by e-mail delivery of a “.pdf” format data file, with the same force and effect as if such facsimile or “.pdf” signature page were an
original thereof. 
 (e) Governing Law. This Agreement shall be governed by and interpreted under the laws of the State
of Texas without giving effect to any conflict of laws provisions. 
 (f) Waiver of Breach. No delay or omission by a
Party to this Agreement in exercising any right, remedy or power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such Party from time to time and as
often as may be deemed expedient or necessary by such Party in its sole discretion. 

  
 5 

 (g) Severability. If any provision of this Agreement or application thereof to anyone
or under any circumstances shall be determined to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions or applications of this Agreement which can be given effect without the invalid or unenforceable
provision or application. 
 (h) Survival. The respective rights and obligations of the Chairman set forth in
Section 6 shall survive the termination of this Agreement to the extent necessary to preserve such rights and obligations; provided, however, that this Section 11(h) shall not extend the rights and obligations set forth in
Section 6(b) beyond the consummation of a merger or consolidation of BPL with or into another partnership, corporation, or other entity, following which the Chairman does not continue to be the Chairman of the Board of the surviving entity.

 [Signature Page Follows] 

  
 6 

 IN WITNESS WHEREOF, the undersigned, intending to be legally bound, have duly
executed this Agreement as of the date first above written. 
  

			
	BUCKEYE GP LLC
		
	By:	 	 /s/ William H. Schmidt, Jr.

	Name:	 	William H. Schmidt, Jr.
	Title:	 	Vice President and General Counsel
	
	CHAIRMAN
	
	 /s/ Forrest E. Wylie

	Forrest E. Wylie

  
 7 

 EXHIBIT A 

Equity Awards 
  

									
	Forrest Wylie - LTIP Summary	 
	 Award Type
	  	Grant Date	 	  	# Units
Granted	 
	 Performance Units
	  	 	4/30/2009	  	  	 	9,534	  
	 Performance Units
	  	 	2/16/2010	  	  	 	23,691	  
	 Performance Units
	  	 	2/9/2011	  	  	 	13,925	  
	 Phantom Units
	  	 	4/30/2009	  	  	 	4,767	  
	 Phantom Units
	  	 	2/16/2010	  	  	 	11,846	  
	 Phantom Units
	  	 	2/9/2011	  	  	 	6,859	  
	 Deferred Units
	  	 	2/18/2010	  	  	 	4,380	  
	 Deferred Units
	  	 	2/18/2011	  	  	 	3,463	  
	 Matching Units
	  	 	2/18/2010	  	  	 	4,380	  
	 Matching Units
	  	 	2/18/2011	  	  	 	3,463	  
		  				  	  
	  
	 
	 TOTAL
	  				  	 	86,308	  
		  				  	  
	  
	 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]